Health and Fitness FDA Approves New Multiple Sclerosis Treatment: Tecfidera by Gary Kopycinski on March 27, 2013 Gary Kopycinski Author More in Health and Fitness: On Hantavirus, Park Forest Officials Urge Caution May 18, 2026 Rep. Kelly Condemns FDA Approval of Flavored E-Cigarettes May 6, 2026 Park Forest Aligns With Illinois Guidance on Childhood Vaccines Amid Federal Changes January 11, 2026 Silver Spring, Maryland–(ENEWSPF)–March 27, 2013. The U.S. Food and Drug Administration today approved Tecfidera (dimethyl fumarate) capsules to treat adults with relapsing forms of multiple sclerosis (MS).